Phase I Trial of Pyragrel, a Novel Thromboxane Synthetase Inhibitor, to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers
发布时间：2023-12-19
点击次数：
影响因子：5.6
DOI码：10.3389/fphar.2019.01231
发表刊物：FRONTIERS IN PHARMACOLOGY
合写作者：Zou, C (Zou, Chan), Huang, J (Huang, Jie), Hua, Y (Hua, Ye), S (Yang, Shuang), XY (Yang, Xiaoyan), Guo, C (Guo, Can), Tan, HY (Tan, Hongyi), Chen, J (Chen, Jun), Chu, ZX (Chu, Zhaoxing), Pei, Q (Pei, Qi), 刘洋, GP (Yang, Guoping)
是否译文：否
发表时间：2019-10-24